510(k) Report

FDA applicant

Randox Laboratories, Ltd.

Crumlin, GB134 decisions1992–202686 recalls

FDA records 134 decisions for Randox Laboratories, Ltd. (Crumlin, GB) from 1992 to 2026: 133 510(k) clearances and 1 De Novo grant. Most are in product codes JJY (Multi-Analyte Controls, All Kinds (Assayed)) and JJX (Single (Specified) Analyte Controls (Assayed…). Since 2016 its 510(k)s took a median of 492 days from receipt to decision, against 140 for FDA’s reviews in the same codes and years. Its devices cite 30 predicates, 10 of them its own earlier devices. 86 recalls are linked to its devices.

FDA’s records also spell it “Randox Laboratories Limited”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Randox Laboratories, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2010: 42011: 82012: 82013: 62014: 52015: 22016: 42017: 32018: 12023: 32025: 12026 (partial year): 1
2007high 8 (2011) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

6in 2024

2013: 22014: 12015: 12016: 52017: 52018: 142019: 162020: 92021: 22022: 82023: 152024: 6
2007high 16 (2019) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Randox Laboratories, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Randox Laboratories, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report